Literature DB >> 26354038

Causes of Death in Adults with Mitochondrial Disease.

Marlieke Barends1,2, Lotte Verschuren1,2, Eva Morava3, Victoria Nesbitt2, Doug Turnbull2, Robert McFarland4.   

Abstract

INTRODUCTION: Mitochondrial diseases are a clinically, biochemically and genetically heterogeneous group of disorders with a variable age of onset and rate of disease progression. It might therefore be expected that this variation be reflected in the age and cause of death. However, to date, little has been reported regarding the 'end-of-life' period and causes of death in mitochondrial disease patients. For some specific syndromes, the associated clinical problems might predict the cause of death, but for many patients, it remains difficult to provide an accurate prognosis. AIMS: To describe a retrospective cohort of adult mitochondrial disease patients who had attended the NHS Highly Specialised Services for Rare Mitochondrial Diseases in Newcastle upon Tyne (UK), evaluate life expectancy and causes of death and assess the consequences for daily patient care.
METHODS: All deceased adult patients cared for at this centre over a period of 10 years were included in the study. Patient history, data on laboratory findings, biochemical investigations and genetic studies were analysed retrospectively.
RESULTS: A total of 30 adult mitochondrial patients died within the time period of the study. The main mitochondrial disease-related causes of death in this patient cohort were respiratory failure, cardiac failure and acute cerebral incidents such as seizures and strokes. In almost half of the patients, the cause of death remained unknown. Based on our study, we present recommendations regarding the care of patients with mitochondrial disease.

Entities:  

Keywords:  Adult patient cohort; Audit; Causes of death; Life expectancy; Mitochondrial disease

Year:  2015        PMID: 26354038      PMCID: PMC4864865          DOI: 10.1007/8904_2015_449

Source DB:  PubMed          Journal:  JIMD Rep        ISSN: 2192-8304


  41 in total

1.  What is Kearns-Sayre syndrome after all?

Authors:  T Ashizawa; S H Subramony
Journal:  Arch Neurol       Date:  2001-07

Review 2.  Mitochondrial respiratory-chain diseases.

Authors:  Salvatore DiMauro; Eric A Schon
Journal:  N Engl J Med       Date:  2003-06-26       Impact factor: 91.245

3.  Cardiac involvement is frequent in patients with the m.8344A>G mutation of mitochondrial DNA.

Authors:  K Wahbi; S Larue; C Jardel; C Meune; T Stojkovic; F Ziegler; A Lombès; B Eymard; D Duboc; P Laforêt
Journal:  Neurology       Date:  2010-02-23       Impact factor: 9.910

4.  MERRF syndrome with overwhelming lactic acidosis.

Authors:  T D Sanger; K D Jain
Journal:  Pediatr Neurol       Date:  1996-01       Impact factor: 3.372

Review 5.  Chronic progressive external ophthalmoplegia: a report of 6 cases and a review of the literature.

Authors:  Pedro Enrique Jiménez Caballero; Monica Serviá Candela; Clara Isabel Cabeza Alvarez; Araceli Alvarez Tejerina
Journal:  Neurologist       Date:  2007-01       Impact factor: 1.398

6.  Psychiatric involvement in adult patients with mitochondrial disease.

Authors:  Michelangelo Mancuso; Daniele Orsucci; Elena Caldarazzo Ienco; Eleonora Pini; Anna Choub; Gabriele Siciliano
Journal:  Neurol Sci       Date:  2011-12-23       Impact factor: 3.307

7.  Early detection of myocardial dysfunction in children with mitochondrial disease: An ultrasound and two-dimensional strain echocardiography study.

Authors:  Karen A Marcus; Marlieke Barends; Eva Morava-Kozicz; Ton Feuth; Chris L de Korte; Livia Kapusta
Journal:  Mitochondrion       Date:  2010-12-13       Impact factor: 4.160

8.  Kearns-Sayre syndrome presenting as complete heart block.

Authors:  Sanjay Chawla; Jorida Coku; Thomas Forbes; Sujatha Kannan
Journal:  Pediatr Cardiol       Date:  2007-08-29       Impact factor: 1.655

Review 9.  Batteries not included: diagnosis and management of mitochondrial disease.

Authors:  R McFarland; D M Turnbull
Journal:  J Intern Med       Date:  2009-02       Impact factor: 8.989

10.  Multiple oxidative phosphorylation deficiencies in severe childhood multi-system disorders due to polymerase gamma (POLG1) mutations.

Authors:  Maaike C de Vries; Richard J Rodenburg; Eva Morava; Edwin P M van Kaauwen; Henk ter Laak; Reinier A Mullaart; Irina N Snoeck; Peter M van Hasselt; Peter Harding; Lambert P W van den Heuvel; Jan A M Smeitink
Journal:  Eur J Pediatr       Date:  2006-09-07       Impact factor: 3.860

View more
  10 in total

Review 1.  Mitochondria-Induced Immune Response as a Trigger for Neurodegeneration: A Pathogen from Within.

Authors:  Marta Luna-Sánchez; Patrizia Bianchi; Albert Quintana
Journal:  Int J Mol Sci       Date:  2021-08-07       Impact factor: 5.923

Review 2.  The Energy Maintenance Theory of Aging: Maintaining Energy Metabolism to Allow Longevity.

Authors:  Snehal N Chaudhari; Edward T Kipreos
Journal:  Bioessays       Date:  2018-06-14       Impact factor: 4.345

Review 3.  Patient care standards for primary mitochondrial disease: a consensus statement from the Mitochondrial Medicine Society.

Authors:  Sumit Parikh; Amy Goldstein; Amel Karaa; Mary Kay Koenig; Irina Anselm; Catherine Brunel-Guitton; John Christodoulou; Bruce H Cohen; David Dimmock; Gregory M Enns; Marni J Falk; Annette Feigenbaum; Richard E Frye; Jaya Ganesh; David Griesemer; Richard Haas; Rita Horvath; Mark Korson; Michael C Kruer; Michelangelo Mancuso; Shana McCormack; Marie Josee Raboisson; Tyler Reimschisel; Ramona Salvarinova; Russell P Saneto; Fernando Scaglia; John Shoffner; Peter W Stacpoole; Carolyn M Sue; Mark Tarnopolsky; Clara Van Karnebeek; Lynne A Wolfe; Zarazuela Zolkipli Cunningham; Shamima Rahman; Patrick F Chinnery
Journal:  Genet Med       Date:  2017-07-27       Impact factor: 8.822

4.  Patient care standards for primary mitochondrial disease in Australia: an Australian adaptation of the Mitochondrial Medicine Society recommendations.

Authors:  Carolyn M Sue; Shanti Balasubramaniam; Drago Bratkovic; Catherine Bonifant; John Christodoulou; David Coman; Karen Crawley; Fabienne Edema-Hildebrand; Carolyn Ellaway; Roula Ghaoui; Maina Kava; Lisa S Kearns; Joy Lee; Christina Liang; David A Mackey; Sean Murray; Merrilee Needham; Rocio Rius; Jacqui Russell; Nicholas J C Smith; Dominic Thyagarajan; Christine Wools
Journal:  Intern Med J       Date:  2021-11-19       Impact factor: 2.611

5.  Defined neuronal populations drive fatal phenotype in a mouse model of Leigh syndrome.

Authors:  Irene Bolea; Alejandro Gella; Elisenda Sanz; Patricia Prada-Dacasa; Fabien Menardy; Angela M Bard; Pablo Machuca-Márquez; Abel Eraso-Pichot; Guillem Mòdol-Caballero; Xavier Navarro; Franck Kalume; Albert Quintana
Journal:  Elife       Date:  2019-08-12       Impact factor: 8.140

6.  Mitochondrial PE potentiates respiratory enzymes to amplify skeletal muscle aerobic capacity.

Authors:  Timothy D Heden; Jordan M Johnson; Patrick J Ferrara; Hiroaki Eshima; Anthony R P Verkerke; Edward J Wentzler; Piyarat Siripoksup; Tara M Narowski; Chanel B Coleman; Chien-Te Lin; Terence E Ryan; Paul T Reidy; Lisandra E de Castro Brás; Courtney M Karner; Charles F Burant; J Alan Maschek; James E Cox; Douglas G Mashek; Gabrielle Kardon; Sihem Boudina; Tonya N Zeczycki; Jared Rutter; Saame Raza Shaikh; Jean E Vance; Micah J Drummond; P Darrell Neufer; Katsuhiko Funai
Journal:  Sci Adv       Date:  2019-09-11       Impact factor: 14.136

7.  Arrhythmia prevalence and sudden death risk in adults with the m.3243A>G mitochondrial disorder.

Authors:  John P Bourke; Yi Shiau Ng; Margaret Tynan; Matthew G D Bates; Saidi Mohiddin; Doug Turnbull; Grainne S Gorman
Journal:  Open Heart       Date:  2022-04

8.  Endocrine Manifestations and New Developments in Mitochondrial Disease.

Authors:  Yi Shiau Ng; Albert Zishen Lim; Grigorios Panagiotou; Doug M Turnbull; Mark Walker
Journal:  Endocr Rev       Date:  2022-05-12       Impact factor: 25.261

Review 9.  Mitochondrial Disorders.

Authors:  Thomas Klopstock; Claudia Priglinger; Ali Yilmaz; Cornelia Kornblum; Felix Distelmaier; Holger Prokisch
Journal:  Dtsch Arztebl Int       Date:  2021-11-05       Impact factor: 8.251

10.  Comment on: "Mitochondrial Mechanisms of Neuromuscular Junction Degeneration with Aging. Cells 2020, 9, 197".

Authors:  Allen Herbst; Judd M Aiken; Debbie McKenzie; Jonathan Wanagat
Journal:  Cells       Date:  2020-07-29       Impact factor: 6.600

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.